NQMC Update Service: October 31, 2016 || Canadian Partnership Against Cancer

NQMC Update Service: October 31, 2016

Canadian Partnership Against Cancer

• Cervical cancer screening: age standardized incidence rate per 100,000 women of invasive cervical cancer—non-squamous cell carcinoma diagnosed in a year.
• Cervical cancer screening: age standardized incidence rate per 100,000 women of invasive cervical cancer—squamous cell carcinoma diagnosed in a year.
• Cervical cancer screening: percentage of invasive carcinoma of the cervix diagnosed at stage 1 in a 12-month period.
• Cervical cancer screening: percentage of Pap tests with an HSIL+ result that have a histological confirmation of HSIL, carcinoma in situ, or invasive carcinoma within 12 months of the HSIL+ Pap test.
• Cervical cancer screening: percentage of Pap tests with ASC-H results that have a histological confirmation of HSIL, carcinoma in situ, or invasive carcinoma within 12 months of the ASC-H Pap test.
• Cervical cancer screening: percentage of women with histology of HSIL per 1000 women who had a Pap test in the previous 12 months.